Tivic Health Systems (Tivic Health Systems) FCF Margin % : -496.92% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tivic Health Systems's Free Cash Flow for the three months ended in Dec. 2023 was $-1.77 Mil. Tivic Health Systems's Revenue for the three months ended in Dec. 2023 was $0.36 Mil. Therefore, Tivic Health Systems's FCF Margin % for the quarter that ended in Dec. 2023 was -496.92%.

As of today, Tivic Health Systems's current FCF Yield % is -559.96%.

The historical rank and industry rank for Tivic Health Systems's FCF Margin % or its related term are showing as below:

TIVC' s FCF Margin % Range Over the Past 10 Years
Min: -881.19 Med: -485.33 Max: -351.98
Current: -733.76

During the past 5 years, the highest FCF Margin % of Tivic Health Systems was -351.98%. The lowest was -881.19%. And the median was -485.33%.

TIVC's FCF Margin % is ranked worse than
91.5% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: -7.13 vs TIVC: -733.76

Tivic Health Systems FCF Margin % Historical Data

The historical data trend for Tivic Health Systems's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tivic Health Systems FCF Margin % Chart

Tivic Health Systems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-881.19

-351.98

-446.46

-485.33

-733.76

Tivic Health Systems Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial										-545.83	-670.21	-1,530.43	-663.48	-496.92

Competitive Comparison of Tivic Health Systems's FCF Margin %

For the Medical Devices subindustry, Tivic Health Systems's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tivic Health Systems's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tivic Health Systems's FCF Margin % falls into.

Tivic Health Systems FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tivic Health Systems's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.629	/	1.176
	=	-733.76 %

Tivic Health Systems's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.774	/	0.357
	=	-496.92 %

Tivic Health Systems FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tivic Health Systems (Tivic Health Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

25821 Industrial Boulevard, Suite 100, Hayward, CA, USA, 94545

Website

https://www.tivichealth.com

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Executives

Sheryle Bolton	director	55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria	director	C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst	director, officer: Chief Executive Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein	officer: Chief Scientific Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia	officer: Chief Operating Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach	officer: Interim CFO	25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler	director	C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai	officer: Chief Financial Officer	C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude	10 percent owner	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz	officer: Chief Financial Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025